1
|
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study.
|
Ann Rheum Dis
|
2010
|
1.34
|
2
|
Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis.
|
Ann Rheum Dis
|
2006
|
0.87
|
3
|
Role of lymphotoxin-alpha in cigarette smoke-induced inflammation and lymphoid neogenesis.
|
Eur Respir J
|
2009
|
0.86
|
4
|
Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade.
|
Ann Rheum Dis
|
2008
|
0.85
|
5
|
Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint.
|
Arthritis Rheum
|
2007
|
0.83
|